Corporate Dems’ Rapidly Growing ‘Dark Money’ Arm Tax documents reveal the group Center Forward received a record $18.8 million in 2021 and spent big to back conservative Democrats who bucked their party on drug pricing reforms.
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.